Oyster Point Pharma, Inc. Stock Split Ratio
Oyster Point Pharma, Inc. reported Stock Split Ratio of 35.30% for the 1-month period ending 2019-10-31, per its 10-K filed 2021-02-18.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2021-02-18
- 2019-10-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 35.30%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|
| 2019-10-31 | 35.30% 10-K · filed 2021-02-18 |